Physician profile
Karan Chugh
NPI 1942588553
$3,838.76
in general payments reported to CMS, 2019-2025
29 companies · $1,822 in 2025
The $1,822 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $37.70 · 2022: $78.61 · 2023: $929 · 2024: $717 · 2025: $1,822.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,775 · Travel and Lodging: $523 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,774.55 |
| Travel and Lodging | $522.96 |
| Education | $169.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $849.29 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $458.60 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $361.37 | 2019-2025 | Airsupra, Fasenra, Breztri |
| Astellas Pharma US INC | $328.44 | 2023-2025 | Ambisome, Cresemba |
| Zoll Respicardia, INC. | $262.73 | 2025 | Remede System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $211.65 | 2019-2023 | Ofev, Stiolto Respimat |
| Amgen INC. | $162.78 | 2019-2025 | Tezspire |
| Abbvie INC. | $149.78 | 2023-2025 | Avycaz, Teflaro |
| Stryker Corporation | $127.28 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Optinose US, INC. | $127.26 | 2024 | |
| United Therapeutics Corporation | $127.09 | 2019-2025 | Tyvaso, Tyvaso |
| Merck Sharp & Dohme LLC | $120.19 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Abiomed | $98.28 | 2025 | |
| Viiv Healthcare Company | $58.55 | 2023-2024 | Cabenuva |
| Gilead Sciences, INC. | $40.03 | 2024-2025 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $39.12 | 2024 | Smartvest |
| La Jolla Pharmaceutical Company | $38.27 | 2023-2024 | Giapreza |
| Baxter Healthcare | $33.38 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Mylan Specialty L.P. | $29.68 | 2019 | |
| Verona Pharma, INC. | $29.48 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $27.22 | 2025 | Dupixent |
| Avadel Cns Pharmaceuticals, LLC | $27.10 | 2025 | Lumryz |
| Biogen, INC. | $26.39 | 2024 | Spinraza |
| Insmed, INC. | $24.60 | 2019 | |
| Philips North America LLC | $19.57 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.83 | 2024 | |
| Viatris Specialty LLC | $14.86 | 2025 | Yupelri |
| Advanced Respiratory, INC | $14.54 | 2019 | |
| Circassia INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karan Chugh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.